Rankings
▼
Calendar
PTCT FY 2017 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$5B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$194M
+135.0% YoY
Gross Profit
$190M
97.6% margin
Operating Income
-$64M
-33.1% margin
Net Income
-$79M
-40.6% margin
EPS (Diluted)
$-2.02
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$13M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$392M
Total Liabilities
$235M
Stockholders' Equity
$156M
Cash & Equivalents
$191M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$194M
$83M
+135.0%
Gross Profit
$190M
-$35M
+643.4%
Operating Income
-$64M
-$132M
+51.3%
Net Income
-$79M
-$142M
+44.4%
← Q4 2016
All Quarters
Q1 2017 →